A/Prof. Yinggang Zhu (Shanghai, China)
A/Prof. Zhu is a Deputy Chief Physician in the Department of Pulmonary and Critical Care Medicine and serves as Head of the Fever Clinic at Huadong Hospital. He is the secretary of the Infectious Disease Group of the Respiratory Medicine Branch of the Chinese Medical Association and a member of the Infection Specialty Committee (IDSC) of the Chinese Medical Education Association, as well as the Critical Care Medicine Working Committee of the Respiratory Physicians Branch of the Chinese Medical Doctor Association (CACP). Additionally, he also collaborates with the European Collaborative Expert Group on Aerosolized Antibiotic Treatment for Ventilator-Associated Pneumonia (ENAVAP).
A/Prof. Zhu has devoted his research to the role and mechanism of mesenchymal stromal cells (MSCs) and their derivatives in treating acute lung injury. His notable work, published in Stem Cells in 2014, has been cited over 700 times and was recognized as one of the top 5 most cited articles in Stem Cells magazine that year. In 2017, he received an international trainee scholarship from the American Thoracic Society, and in 2022, he was honored as the Wiley China Open Science Scholar of the Year.
A/Prof. Zhu is a Deputy Chief Physician in the Department of Pulmonary and Critical Care Medicine and serves as Head of the Fever Clinic at Huadong Hospital. He is the secretary of the Infectious Disease Group of the Respiratory Medicine Branch of the Chinese Medical Association and a member of the Infection Specialty Committee (IDSC) of the Chinese Medical Education Association, as well as the Critical Care Medicine Working Committee of the Respiratory Physicians Branch of the Chinese Medical Doctor Association (CACP). Additionally, he also collaborates with the European Collaborative Expert Group on Aerosolized Antibiotic Treatment for Ventilator-Associated Pneumonia (ENAVAP).
A/Prof. Zhu has devoted his research to the role and mechanism of mesenchymal stromal cells (MSCs) and their derivatives in treating acute lung injury. His notable work, published in Stem Cells in 2014, has been cited over 700 times and was recognized as one of the top 5 most cited articles in Stem Cells magazine that year. In 2017, he received an international trainee scholarship from the American Thoracic Society, and in 2022, he was honored as the Wiley China Open Science Scholar of the Year.